undamentalytics Newsletter
Sign in

Globus Medical Inc cash flow statement

In fiscal 2025, Globus Medical Inc's operations generated $753m of cash; it spent $165m on capital projects, leaving free cash flow of $589m. It returned $300m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations7176779379124148159182172199276178243521753910
Depreciation and amortisation15171819222439424253637068146253277221
Stock-based pay43557101115222627313353545049
Capital spending1222252425514151607164577478115165155
Free cash flow595452705473107108122101135219104165405589756
Free cash flow after stock pay55514765476496931007510818972112351539707
Share buybacks01000——————105—14422686300221
Shares issued112810————————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: GMED vs PODDGMED vs RVTYGMED vs QDEL

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Globus Medical Inc's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Globus Medical Inc.